Purple Biotech (PPBT) Non-cash Items (2017 - 2026)

Purple Biotech (PPBT) has 10 years of Non-cash Items data on file, last reported at -$2.1 million in Q1 2026.

• On a quarterly basis, Non-cash Items fell 65.06% year-over-year to -$2.1 million in Q1 2026; TTM through Mar 2026 was -$7.3 million, a 1.93% decrease from a year earlier, with the FY2025 full-year figure at -$6.5 million, up 35.59% from the prior year.
• Non-cash Items for Q1 2026 stood at -$2.1 million, up from -$3.0 million in the prior quarter.
• Over the last five years, Non-cash Items for PPBT reached as high as -$1.0 million in Q4 2024 and fell as low as -$7.0 million in Q1 2022.
• Historically, Non-cash Items has averaged -$3.5 million across 5 years, with a median of -$3.0 million in 2022.
• Across the five-year window, Non-cash Items surged 83.27% in 2024 and tumbled 192.38% in 2025, its largest moves.
• Year by year, Non-cash Items stood at -$5.7 million in 2022, then dropped by 5.71% to -$6.0 million in 2023, then jumped by 83.27% to -$1.0 million in 2024, then tumbled by 192.38% to -$3.0 million in 2025, then gained by 29.12% to -$2.1 million in 2026.
• Per Business Quant data, the three most recent Non-cash Items figures were -$2.1 million in Q1 2026, -$3.0 million in Q4 2025, and -$1.1 million in Q3 2025.